Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1844417 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.72Day −7.57%Mkt cap $31M1Y −17.7%Off 52W high −77.1%Vol (1Y) 115.5%
Daily closing price, split-adjusted to the current basis; 2.8y shown of 704 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.1% of sh out |
| Days to cover1.2d |
| 13F net flow (QoQ)+0.01% |
| Top-10 13F concentration99.5% |
| Next report (est.)2026-08-17 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$13.3M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−53.8% |
| 1Y−17.7% |
| Since incept. (ann.)−42.7% |
Total return through 2026-07-30 · series begins 2023-10-02. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)115.5% |
| Ann. volatility (3Y)110.6% |
| Sharpe (1Y)0.32 |
| Sharpe (3Y)0.03 |
| Max drawdown (1Y)−76.4% |
| Max drawdown (3Y)−79.2% |
| Beta (3Y vs SPY)1.97 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4.1M | $4M | 9.61% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 382,469 | $405,417 | 0.90% | new |
| WELLS FARGO & COMPANY/MN | 264,388 | $280,251 | 0.62% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 157,485 | $166,933 | 0.37% | +43.4% |
| VANGUARD FIDUCIARY TRUST CO | 64,921 | $68,816 | 0.15% | new |
| RENAISSANCE TECHNOLOGIES LLC | 62,795 | $66,563 | 0.15% | −48.7% |
| STATE STREET CORP | 43,252 | $45,847 | 0.10% | +0.0% |
| BlackRock, Inc. | 39,890 | $42,283 | 0.09% | +50.7% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-18 | −$0.05 | — | — | — |
| 2025-09-30 | 2025-11-12 | −$0.13 | — | — | — |
| 2025-06-30 | 2025-08-12 | −$0.15 | — | — | — |
| 2025-03-31 | 2025-05-14 | −$0.06 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-17 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
